To Cite:
Hashemi Shahri
S M, Dehghan
J, Bameri
Z, Kor
A, Sharifi Mood
B, et al. Evaluation of Serum Level of Interleukin-6 in Patients With Crimean-Congo Hemorrhagic Fever in Zahedan, Iran, From 2012 to 2015,
Arch Clin Infect Dis.
2016
; 11(3):e28029.
doi: 10.5812/archcid.28029.
1.
Keshtkar-Jahromi M, Sajadi MM, Ansari H, Mardani M, Holakouie-Naieni K. Crimean-Congo hemorrhagic fever in Iran. Antiviral Res. 2013; 100(1): 20-8[DOI][PubMed]
2.
Sharifi-Mood B, Metanat M, Alavi-Naini R. Prevalence of crimean-congo hemorrhagic Fever among high risk human groups. Int J High Risk Behav Addict. 2014; 3(1)[DOI][PubMed]
3.
Sharifi-Mood B, Mardani M, Keshtkar-Jahromi M, Rahnavardi M, Hatami H, Metanat M. Clinical and epidemiologic features of Crimean-Congo hemorrhagic fever among children and adolescents from southeastern Iran. Pediatr Infect Dis J. 2008; 27(6): 561-3[DOI][PubMed]
4.
Sharifi-Mood B, Metanat M, Ghorbani-Vaghei A, Fayyaz-Jahani F, Akrami E. The Outcome of Patients with Crimean-Congo Hemorrhagic Fever in Zahedan, southeast of Iran: A Comparative Study . Arch Iranian Med. 2009; 12(2)
5.
Hashemi-Shahri S, Sharifi-Mood B, Metant M. Risk Factors Associated With Poor Prognosis in Children With Crimean-Congo Hemorrhagic Fever. Int J Infect. 2014; 1(3): 7-12
6.
Chinikar S. An overview of Crimean-Congo Hemorrhagic Fever in Iran. Iranian J Microbiol. 2009; 1(1): 7-12
7.
Mardani M,
Rahnavardi M,
Rajaeinejad M,
Naini KH,
Chinikar S,
Pourmalek F,
et al.
Crimean-Congo hemorrhagic fever among health care workers in Iran: a seroprevalence study in two endemic regions. Am J Trop Med Hyg. 2007; 76(3): 443-5[PubMed]
8.
Mardani M, Keshtkar-Jahromi M, Ataie B, Adibi P. Crimean-Congo hemorrhagic fever virus as a nosocomial pathogen in Iran. Am J Trop Med Hyg. 2009; 81(4): 675-8[DOI][PubMed]
9.
Chinikar S,
Ghiasi SM,
Moradi M,
Goya MM,
Shirzadi MR,
Zeinali M,
et al.
Geographical distribution and surveillance of Crimean-Congo hemorrhagic fever in Iran. Vector Borne Zoonotic Dis. 2010; 10(7): 705-8[DOI][PubMed]
10.
Keshtkar Jahromi M. Crimean-Congo Hemorrhagic Fever-Treatment and Preventive Strategies. Int J Infect. 2014; 1(2)
11.
Anderson R, Wang S, Osiowy C, Issekutz AC. Activation of endothelial cells via antibody-enhanced dengue virus infection of peripheral blood monocytes. J Virol. 1997; 71(6): 4226-32[PubMed]
13.
Madonna R, Pandolfi A, Massaro M, Consoli A, De Caterina R. Insulin enhances vascular cell adhesion molecule-1 expression in human cultured endothelial cells through a pro-atherogenic pathway mediated by p38 mitogen-activated protein-kinase. Diabetologia. 2004; 47(3): 532-6[DOI][PubMed]
15.
Ergonul O, Tuncbilek S, Baykam N, Celikbas A, Dokuzoguz B. Evaluation of serum levels of interleukin (IL)-6, IL-10, and tumor necrosis factor-alpha in patients with Crimean-Congo hemorrhagic fever. J Infect Dis. 2006; 193(7): 941-4[DOI][PubMed]
16.
Sancakdar E,
Guven AS,
Uysal EB,
Kaya A,
Deveci K,
Karapinar H,
et al.
Evaluation of cytokines as Th1/Th2 markers in pathogenesis of children with Crimean-Congo hemorrhagic fever. Int J Clin Exp Med. 2014; 7(3): 751-7[PubMed]
17.
Kaya S,
Elaldi N,
Kubar A,
Gursoy N,
Yilmaz M,
Karakus G,
et al.
Sequential determination of serum viral titers, virus-specific IgG antibodies, and TNF-alpha, IL-6, IL-10, and IFN-gamma levels in patients with Crimean-Congo hemorrhagic fever. BMC Infect Dis. 2014; 14: 416[DOI][PubMed]
18.
Deveci K,
Oflaz MB,
Sancakdar E,
Uysal EB,
Guven AS,
Kaya A,
et al.
Evaluation of the serum levels of soluble IL-2 receptor and endothelin-1 in children with Crimean-Congo hemorrhagic fever. APMIS. 2014; 122(7): 643-7[DOI][PubMed]
19.
Ozsurekci Y,
Arasli M,
Karadag Oncel E,
Caglayik DY,
Kaya A,
Icagasioglu FD,
et al.
Can the mild clinical course of crimean-congo hemorrhagic fever in children be explained by cytokine responses? J Med Virol. 2013; 85(11): 1955-9[DOI][PubMed]
20.
Dokuzoguz B, Celikbas AK, Gok SE, Baykam N, Eroglu MN, Ergonul O. Severity scoring index for Crimean-Congo hemorrhagic fever and the impact of ribavirin and corticosteroids on fatality. Clin Infect Dis. 2013; 57(9): 1270-4[DOI][PubMed]
21.
Bakhtiari K, Meijers JC, de Jonge E, Levi M. Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation. Crit Care Med. 2004; 32: 2416-21
22.
Bente DA,
Alimonti JB,
Shieh WJ,
Camus G,
Stroher U,
Zaki S,
et al.
Pathogenesis and immune response of Crimean-Congo hemorrhagic fever virus in a STAT-1 knockout mouse model. J Virol. 2010; 84: 11089-100
23.
Bakir M, Engin A, Gozel MG, Elaldi N, Kilickap S, Cinar Z. A new perspective to determine the severity of cases with Crimean-Congo hemorrhagic fever. J Vector Borne Dis. 2012; 49(2): 105-10[PubMed]
24.
Cevik MA,
Erbay A,
Bodur H,
Eren SS,
Akinci E,
Sener K,
et al.
Viral load as a predictor of outcome in Crimean-Congo hemorrhagic fever. Clin Infect Dis. 2007; 45(7)-100[DOI][PubMed]
25.
Dewi BE, Takasaki T, Kurane I. Peripheral blood mononuclear cells increase the permeability of dengue virus-infected endothelial cells in association with downregulation of vascular endothelial cadherin. J Gen Virol. 2008; 89: 642-52[DOI][PubMed]
26.
Papa A, Bino S, Velo E, Harxhi A, Kota M, Antoniadis A. Cytokine levels in Crimean-Congo hemorrhagic fever. J Clin Virol. 2006; 36(4): 272-6[DOI][PubMed]
Readers' Comments